chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Disoriented (Agent Observation); Hard to hear (Agent Observation); Vision dropped by 50%  After Second Dose; Can not read Newspaper After Second Dose; Headache After Second Dose; Flu Like Symptoms After Second Dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu Like Symptoms After Second Dose), VISUAL IMPAIRMENT (Vision dropped by 50%  After Second Dose), READING DISORDER (Can not read Newspaper After Second Dose), CONFUSIONAL STATE (Disoriented (Agent Observation)) and HYPOACUSIS (Hard to hear (Agent Observation)) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu Like Symptoms After Second Dose) and HEADACHE (Headache After Second Dose). In March 2021, the patient experienced VISUAL IMPAIRMENT (Vision dropped by 50%  After Second Dose) and READING DISORDER (Can not read Newspaper After Second Dose). On 09-Jun-2021, the patient experienced CONFUSIONAL STATE (Disoriented (Agent Observation)) and HYPOACUSIS (Hard to hear (Agent Observation)). On 23-Feb-2021, HEADACHE (Headache After Second Dose) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu Like Symptoms After Second Dose), VISUAL IMPAIRMENT (Vision dropped by 50%  After Second Dose), READING DISORDER (Can not read Newspaper After Second Dose), CONFUSIONAL STATE (Disoriented (Agent Observation)) and HYPOACUSIS (Hard to hear (Agent Observation)) outcome was unknown.            The patient reported he visited an eye doctor on 26-MAY-2021 and was told his vision problems might be due to his age. The eye doctor prescribed glasses but the patient had not yet purchased them at the time of the report.  No concomitants medication were provided. No lab data has been provided by the reporter.
Headache; joint pain; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 03Apr2021 at 15:30, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication included zolpidem tartrate (AMBIEN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021, the patient experienced headache and joint pain for 24 hours and muscle aches for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event headache and joint pain resolved in duration of 24 hours in Apr2021 and the event muscle aches resolved in duration of 48 hours in Apr2021.  No follow-up attempts are needed. No further information is expected.
Expired MMRlI administered; This spontaneous report was received from a licensed practical nurse and refers to a 77-year-old male patient. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On 15-JUN-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHa)) (M-M-R II) lot # S014807, expiration date 13-MAY-2021 (formulation, dose, route of administration, anatomical location were not reported) for prophylaxis.
Flu like symptoms; aches; congestion; fatigue; This is a spontaneous report from a contactable consumer or other non-health care professional. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 18Feb2021 08:00 AM ((at the age of 47-years-old) as dose 2, single for covid-19 immunization. The patient medical history included overweight, high blood pressure and bipolar depression. The patient's concomitant medications were not reported. The patient previously took augmentin and had allergy. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient had not received any other medications in four weeks. On 18Feb2021, the patient experienced flu like symptoms (aches, congestion, fatigue - no fever) for 24 hours after the shot. Then patient was perfectly fine. Patient had not received any treatment for the events. Outcome of the events was recovered on an unspecified date in Feb2021.  Follow-up attempts completed. No further information expected.
Patient's arm became extremely swollen and red for 5 days. Swelling and redness resolved after 5 days
12 days after MMR and Varivax, febrile illness and petechia, requiring hospitalization r/o sepsis. Had zero neutrophils. Bone marrow required: child recovered. Submitted report due to timing of event after MMR/Varivax.
6:00pm- 8:00 pm Stiff neck, swollen glands in neck,   headache  10:00pm face became numb in the evening 2 days lump under left arm  [glands removed right side Contacted Dr. via Portal she advised second shot on 28 June 2021
Approximately 8 days after administration, the site of administration became sore, then burning and painful sensations began on day 11 following administration. It is itchy as we are speaking.
pt received vaccine in right deltoid. went to the observation area. Pt denied pain or problem. pt noticed bleeding from injection site on shirt. staff/RN notified. Pressure and dressing - gauze applied. Remained in observation area for 30 min. no further bleeding noted.  pt denied pain. denied dizziness or lightheadedness. upon discharge, encouraged to go home apply ice pack interm for 20 min each time and decrease usage of right arm today.  seek medical help if bleeding resumes, unable to stop bleeding or develops pain or distress. pt acknowledged instructions
No additional AE details or PQC; inadvertently administered an expired PNEUMOVAX 23; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.       On 13-OCT-2021, the patient was inadvertently vaccinated with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 mL, lot # T021329, expiration date 03-OCT-2021; strength, route of administration and anatomical location were not reported) for prophylaxis, which was administered 10 days after it's expiration date (expired product administered). The pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) had not experienced any temperature excursions. No additional adverse event (AE) details or product quality complaint (PQC) were reported.
Fever 103. 8x8 irregular red area on (L) arm, warm to touch. Tx: MOTRIN.
got a terrible rash; pain even a month later I still have pain; This case was reported by a consumer and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash and pain. On an unknown date, the outcome of the rash and pain were recovered/resolved.   It was unknown if the reporter considered the rash and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient reported that, he/she had the shot of Shingles vaccine and still got a terrible rash and pain. For the tolerance of the 2nd dose, refer case US2021AMR175260, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR175260:Same reporter
Patient reported mild stinging and itching at the injection area. The reaction appeared like ant bites that were red and raised in a 2" by 3" inch area at the injection site.
Pain and numbeness in arm for 2 days after vaccine administered.  Malaise and intermittant nausea since day of vaccination.
Headache, Myalgia, Arthralgia, Fever, Chills, Fatigue, Erythema, Injection site pain,
Severe Nausea experienced 8 hours after the IM injection Treated with Zofran, Omeprazole, Diphenhydramine and Pepto-Bismol
Right arm intense pain from my shoulder all the way to my fingers. Could hardly move my arm. After a week, it still hurts at the shoulder.
Pt stated she experienced some tenderness at injection site. Later in day after injection approximately 4 days after injection she c/o bilateral forearm and wrist pain and tenderness in (L) foot. Approximately 10 days after injection c/o pain in arms, wrists, ankles and knees. Pt was tx'd with Levaquin, Doxycycline, Lor-Tab, Toradol, and Prednisone with minimal relief. Urgent care visits x 2 ER x 2 and PCP x 1.
(L) upper arm, redness, cellulitis; minimal tenderness; ROM good. Warm compresses x oral antibiotics.
DVT left saphenous vein and left common femoral vein.  Redness and tenderness inside of left thigh x 2 days. Got an ultrasound 1/29/21 that confirmed DVT. Treatment: eliquis x 3 months and for as long as I'm on tamoxifen. If discontinuing tamoxifen, daily aspirin recommended.
Has enlarged lymph node on clavicular area. C/O headache and fatigue (left side).
SEVERE FLUSHING, PALPITAIONS, DIZZINESS, WEAKNESS, BURNING SENSATION IN THE EYES & IN THE HEAD.
Severe joint point in both knees, hips, elbows, shoulders and right wrist.  Severity of pain varies but is consistent and significant enough to prevent regular nightly sleep.  Typical approaches to alleviating the pain, which does occur in the knees and hips due to early arthritis, are not effective.  These include OTC rapid release extra strength tylenol and rest.
experienced a "flare up", gastroenterological in nature; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a "flare up", gastroenterological in nature, and was started on budesonide 9mg daily. Patient was scheduled to receive her second dose on 08Jan2021. The pharmacist was calling to see if there are any known interactions between the COVID-19 vaccine and the steroid budesonide. Outcome of event was unknown.   information about lot/batch number has been requested.
earache; if adverse events are related to weight; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 42 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EAR PAIN (non-serious), outcome "unknown", described as "earache"; WEIGHT ABNORMAL (non-serious), outcome "unknown", described as "if adverse events are related to weight".  Additional information: Reporter asked on behalf of her son, 42 years of age. She was asking if adverse events are related to weight. The patient yet to receive his second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4wk p/vax had new onset sz considered to be cryptogenic sz per neuro still cont;no family hx sz;still w/sz;
Other related health conditions; Shingles; Information has been received regarding a case in litigation and refers to 52-year-old female patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. In or about March 2018, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (also reported as shingles vaccine) for prophylaxis (dose, dose number, route, anatomical site of vaccination, lot # and expiration date were not provided) at a pharmacy (she was 52-year-old when she received the vaccine). In or about 2018, as a result of her receipt of zoster vaccine live (ZOSTAVAX), she suffered shingles, including any and all of its sequelae. On an unknown date, she also experienced other related health conditions (ill-defined disorder). As a result of her receipt of zoster vaccine live (ZOSTAVAX), the patient had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages and loss of consortium damages. In addition, the patient required and would continue to require healthcare and services. She had incurred and would continue to incur medical and related expenses. Besides, she had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. The outcome of herpes zoster and ill-defined disorder was reported as not recovered. The causal relationship between the events and zoster vaccine live (ZOSTAVAX) was assessed as related.  Herpes zoster and ill-defined disorder were considered disabling events by the reporter.
Developed heart significant heart palpitations. Hypersensitivity to stimulants (caffeine). Palpitations frequency diminished with removal of stimulants. Hypersensitivity persisted for approximately 6 weeks. Currently no hypersensitivity, and no palpitation events for approximately 90 days.
Dizziness, Headache, Myalgia, Fever, HYPERtension, fatigue, Narrative:  Other Relevant History:
No additional AE; patient was admnistered GARDASIL 9 that had undergone a temperature excursion; This spontaneous report as received from a physician assistant refers to a male patient of unknown age.      The patient's concurrent conditions, medical history, and concomitant medications were not reported.   On an unknown date, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) that had undergone a temperature excursion (product storage error) (lot # S033308 has been verified to be a valid lot number, expiration date reported as 06-AUG-2021, but upon internal validation established as 08-APR-2022); the patient received 1 injection (dose number, route of administration, and anatomical location were not reported) for prophylaxis.    The temperature excursion occurred within 2020 (reported as the past year), but the patient received the dose. The physician assistant was unsure of the administration date but it was before the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) expiration date on the product label. No additional AE/PQC details were obtained.
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.            No concomitant medication was reported.  No treatment medication was reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Provider hospital summary "78 y.o male with a PMH of hyperlipidemia, HTN, AAA, cardiomyopathy, COPD, CAD s/p MI and hx CVA 2014, who presented to the ED with generalized weakness and suspecting COVID infection. He remained stable on RA. He is still somewhat confused but compliant. He will complete a course of dexamethasone at home."  Patient readmitted one day after discharge Provider summary "patient is a 78 YO M who presented with failure to thrive due to COVID-19 infection. Main symptoms were severe fatigue and anorexia, fever, inability to take care of himself. On admission he was not hypoxic. He was treated with supportive care and regeneron. Unfortunately, patient developed hypoxia due to COVID-19 on 12/12, requiring up to 5L NC. He was started on decadron and evaluation showed no convincing evidence of PE. He improved with decadron treatment and was weaned to 3L. PT/OT had been working with him since admission and he steadily improved, and was able to walk >150 feet with stand-by assist and FWW. He no longer qualified for SNF.    He will be discharged home with covid at home program, home pt/ot/RN, and 3L NC. Complete 10 day decadron course with 4 more days. Follow-up with PCP. "
pt recvd vax 16AUG92 & w/in 48 hrs of vax pt devel stiff neck, h/a, malaise & cold sores; malaise persisted approx 1 wk; it took 2 wks for fever blisters to heal;
Shots didn't give you shingles?/suspected vaccination failure; Shingles/ has had it what three, four times; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 16-Sept-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient asked are you sure that the shots did not give you shingles. The patient stated that everyone he knew that had gotten them, had gotten either the jab or the Covid jab(known side effect look up the documents) and everyone he knew that had gotten the vid had been jabbed, no one that have not had gotten them. The patient himself have had them what three to four times. The case was linked with case US2022AMR134291, reported by same reporter. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR134291:Same reporter
Slight fever started then 101F; had given Tylenol in doctor's office. No other symptoms of illness until a few hours later when increased temperature to 102F. Parents reported some tremors/shaking of arms. Taken to ER and overnight observation. Impression from doctor's notes-fever most likely a reaction to IZ with questionable seizure activity; due to fever, most likely.
big rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (big rash all over body) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0BM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced RASH (big rash all over body). At the time of the report, RASH (big rash all over body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient given Moderna for a booster vaccine although patient is under 18. Patient received 2 doses of Pfizer previously. Parent contacted and made aware. Potential side effects counseled on. No current symptoms as of 6:24 pm on 11/17/2021.
Adverse event: Hives in the joint area-hands, knees, elbows, and ankles.  Treatment: calamine lotion and otc allergy medicine.
Patient calling for Chronic COVID-19 Vaccine, Arm Pain, and Skin Problem (burning senstion- upper extremeties ) Symptoms started x1 month. Symptoms include: Received covid-19 vaccine. Patient has had a burning sensation since in arm since vaccine. States sensation has been spreading to the rest of her body. Patient Has not attempted treatment at home.. Pertinent negatives include: Afebrile. HISTORY OF PRESENT ILLNESS Patient is a 41 y.o. female who presents regarding a potential concern for an adverse reaction to the COVID-19 vaccine.    Second Dose in Series: Vaccine was obtained from the clinic/location:  on the date of: May 14th  and approximate time of 2:30  Vaccine was administered to patient's: Right Deltoid Vaccine manufacture was: Pfizer No Previous Reactions to other immunizations   Known COVID Exposure since receiving vaccination?: No   Patient notes the following symptoms: Headache, Localized injection site pain and Myalgias  Patient is a 41-year-old female presenting with multiple different symptoms post COVID-19 vaccine.  Patient reports that has any burning sensation in her vaccine arm.  She reports that it almost feels like it is on fire or sunburn.  Patient reports that at times the sensation travels to different parts of her body.  She also reports that she had neck pain,  Back pain, and upper chest discomfort.  That time she reports that she has some numbness and tingling bilateral to her upper extremities.  She denies any weakness.  She denies any level of consciousness changes.  She denies any trauma. She does not a family history of stroke or neurological problems.  She also reports that she has had a change in her menstrual cycle.  She reports that she is had 2 menstrual periods in the month of May and also in June.  She also reports mild headache.  She also reports that her eyes seem a little dry and feels as though her vision may be getting worse.   1. Adverse effect of vaccine, initial encounter   At this time due to multiple different neurological symptoms and unable to do a good thorough neuro exam I would like her to be seen in person for further evaluation.  Patient was educated on worsening symptoms and reasons to go to the emergency room right away such as any signs of the stroke which we discussed speech changes, numbness or tingling down one arm.  Patient was agreeable to plan of care and is going to reach out to her primary care doctor.     Called PCP office to let them know my recommendation for appointment as soon as available  This visit was completed via health visit and 11-20 mins was spent as part of care with patient.
PATIENT WAS GIVEN A TETANUS SHOT WHILE IN THE ER DEPARTMENT AT 03:00AM FOR A LACERATION TO HER HEAD.  SHE WAS TOLD THAT THE INJECTION WAS ONLY TETANUS BUT FOUND LATER THAT IT WAS DIPTHERIA AND TETANUS COMBINATION.  LATER THE SAME MORNING SHE HAD SORE THROAT AND SWOLLEN GLANDS. FEELS LIKE THROAT AND TONGUE ARE SWOLLEN.  USED BENADRYL AND DISCONTIUED PAIN MEDS.  WAS PRESCRIBED ULTRAM AT ER.